Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Exchange Rate Effect (2022 - 2025)

Historic Exchange Rate Effect for Viking Therapeutics (VKTX) over the last 4 years, with Q3 2025 value amounting to -$6000.0.

  • Viking Therapeutics' Exchange Rate Effect rose 7931.03% to -$6000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$91000.0, marking a year-over-year decrease of 27916.67%. This contributed to the annual value of -$148000.0 for FY2024, which is 39333.33% down from last year.
  • Viking Therapeutics' Exchange Rate Effect amounted to -$6000.0 in Q3 2025, which was up 7931.03% from -$12000.0 recorded in Q2 2025.
  • Viking Therapeutics' 5-year Exchange Rate Effect high stood at $141000.0 for Q4 2022, and its period low was -$223000.0 during Q3 2022.
  • Its 4-year average for Exchange Rate Effect is -$21307.7, with a median of -$9000.0 in 2023.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first soared by 20000.0% in 2024, then tumbled by 50000.0% in 2025.
  • Quarter analysis of 4 years shows Viking Therapeutics' Exchange Rate Effect stood at $141000.0 in 2022, then crashed by 64.54% to $50000.0 in 2023, then crashed by 248.0% to -$74000.0 in 2024, then surged by 91.89% to -$6000.0 in 2025.
  • Its last three reported values are -$6000.0 in Q3 2025, -$12000.0 for Q2 2025, and $1000.0 during Q1 2025.